ACTRN12615001288516
Completed
Not Applicable
The effect of two volumes of intravenous Plasma-Lyte 148 (20 mL/Kg and 2 mL/kg) on the incidence of a decrease in systolic blood pressure of greater than or equal to 25% from baseline during intravenous sedation for elective colonoscopy in adult patients.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Melbourne Health
- Enrollment
- 150
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Presenting for elective colonoscopy with or without gastroscopy
- •Successful oral bowel preparation
- •Planned intravenous sedation by an anaesthetist
- •Able to communicate in English
- •No prior intravenous fluid administration
- •No planned intravenous fluid administration
- •No contraindication to intravenous fluid administration (e.g. uncontrolled heart failure or end\-stage renal failure)
Exclusion Criteria
- •Presenting for emergency colonoscopy
- •Unsuccessful oral bowel preparation
- •Planned intravenous sedation by a non\-anaesthetist
- •Unable to communicate in English
- •Prior intravenous fluid administration
- •Planned intravenous fluid administration
- •Contraindication to intravenous fluid administration (e.g. uncontrolled heart failure or end\-stage renal failure)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Investigating the effect of simultaneous infusion of lidocaine and ketamine compared to single infusion of lidocaine and ketamine on neuromonitoring in spine surgeriesIRCT20230204057318N2Shahid Beheshti University of Medical Sciences90
Recruiting
Phase 3
comparative effect of Ibuprofen and ketorolac in Renal colicRenal colice.Unspecified renal colicIRCT20231112060025N1Ghoum University of Medical Sciences76
Active, not recruiting
Not Applicable
Plasma pharmacokinetic study of once versus twice daily abacavir as part of combination antiretroviral therapy in children with HIV-1 infection aged 3 months to <36 months - Once versus twice dails abacavirEUCTR2005-004433-18-DEFondazione P E N T A18
Completed
Not Applicable
Plasma pharmacokinetic study of once versus twice daily abacavir as part of combination antiretroviral therapy in children with human immunodeficiency virus-1 infection aged 3 months to less than 36 monthsPaediatric HIVInfections and InfestationsISRCTN38147516PENTA Foundation (Italy)18
Not yet recruiting
Phase 3
Comparison between effects of intravenous infusion Ibuprofen vs Morphine – Paracetamol on blood Platelet functioIRCT20210506051200N1Shahid Beheshti University of Medical Sciences30